My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 259

    1.

    Peroxisome proliferator-activated receptor-gamma2 polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes: The Berlin Diabetes Mellitus (BeDiaM) Study.

    Herrmann SM, Ringel J, Wang JG, Staessen JA, Brand E; Berlin Diabetes Mellitus (BeDiaM) Study.

    Diabetes. 2002 Aug;51(8):2653-7.PMID: 12145184 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    The human peroxisome proliferator-activated receptor gamma2 (PPARgamma2) Pro12Ala polymorphism is associated with decreased risk of diabetic nephropathy in patients with type 2 diabetes.

    Caramori ML, Canani LH, Costa LA, Gross JL.

    Diabetes. 2003 Dec;52(12):3010-3.PMID: 14633865 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Association of the PRO12ALA polymorphism of the PPAR-gamma2 gene with oxidized low-density lipoprotein and cardiolipin autoantibodies in nondiabetic and type 2 diabetic subjects.

    Niskanen L, Lindi V, Erkkilä A, Sivenius K, Luoma J, Ylä-Herttuala S, Laakso M, Uusitupa MI.

    Metabolism. 2003 Feb;52(2):213-7.PMID: 12601635 [PubMed - indexed for MEDLINE]Related articles

    4.

    [Association of Pro12Ala variant in peroxisome proliferator-activated receptor-gamma2 gene with type 2 diabetes mellitus]

    Fu M, Chen H, Li X, Li J, Wu B, Cheng L, Cai M, Fu Z.

    Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2002 Jun;19(3):234-8. Chinese. PMID: 12048686 [PubMed - indexed for MEDLINE]Related articles

    5.

    Studies of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPAR-gamma2) gene in relation to insulin sensitivity among glucose tolerant caucasians.

    Ek J, Andersen G, Urhammer SA, Hansen L, Carstensen B, Borch-Johnsen K, Drivsholm T, Berglund L, Hansen T, Lithell H, Pedersen O.

    Diabetologia. 2001 Sep;44(9):1170-6.PMID: 11596673 [PubMed - indexed for MEDLINE]Related articles

    6.

    Impact of the Peroxisome Proliferator Activated Receptor gamma2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus.

    Meirhaeghe A, Fajas L, Helbecque N, Cottel D, Auwerx J, Deeb SS, Amouyel P.

    Int J Obes Relat Metab Disord. 2000 Feb;24(2):195-9.PMID: 10702770 [PubMed - indexed for MEDLINE]Related articles

    7.

    A Pro12Ala polymorphism in the human peroxisome proliferator-activated receptor-gamma 2 is associated with combined hyperlipidaemia in obesity.

    Swarbrick MM, Chapman CM, McQuillan BM, Hung J, Thompson PL, Beilby JP.

    Eur J Endocrinol. 2001 Mar;144(3):277-82.PMID: 11248748 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Pro12Ala of the peroxisome proliferator-activated receptor-gamma2 gene is associated with lower serum insulin levels in nonobese African Americans: the Atherosclerosis Risk in Communities Study.

    Kao WH, Coresh J, Shuldiner AR, Boerwinkle E, Bray MS, Brancati FL; Atherosclerosis Risk in Communities Study.

    Diabetes. 2003 Jun;52(6):1568-72.PMID: 12765972 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism is associated with reduced risk for ischemic stroke with type 2 diabetes.

    Lee BC, Lee HJ, Chung JH.

    Neurosci Lett. 2006 Dec 20;410(2):141-5. Epub 2006 Nov 3.PMID: 17084528 [PubMed - indexed for MEDLINE]Related articles

    10.

    The Pro12Ala polymorphism of PPARgamma2 gene and susceptibility to type 2 diabetes mellitus in a Polish population.

    Malecki MT, Frey J, Klupa T, Skupien J, Walus M, Mlynarski W, Sieradzki J.

    Diabetes Res Clin Pract. 2003 Nov;62(2):105-11.PMID: 14581147 [PubMed - indexed for MEDLINE]Related articles

    11.

    A possible association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma2 gene with obesity in native Javanese in Indonesia.

    Danawati CW, Nagata M, Moriyama H, Hara K, Yasuda H, Nakayama M, Kotani R, Yamada K, Sakata M, Kurohara M, Wiyono P, Asdie H, Sakaue M, Taniguchi H, Yokono K.

    Diabetes Metab Res Rev. 2005 Sep-Oct;21(5):465-9.PMID: 15739197 [PubMed - indexed for MEDLINE]Related articles

    12.

    Gly482Ser polymorphism of the peroxisome proliferator-activated receptor-gamma coactivator-1 gene might be a risk factor for diabetic retinopathy in Slovene population (Caucasians) with type 2 diabetes and the Pro12Ala polymorphism of the PPARgamma gene is not.

    Petrovic MG, Kunej T, Peterlin B, Dovc P, Petrovic D.

    Diabetes Metab Res Rev. 2005 Sep-Oct;21(5):470-4.PMID: 15782399 [PubMed - indexed for MEDLINE]Related articles

    13.

    Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma2 (PPARgamma2) is associated with higher levels of total cholesterol and LDL-cholesterol in male caucasian type 2 diabetes patients.

    Zietz B, Barth N, Spiegel D, Schmitz G, Schölmerich J, Schäffler A.

    Exp Clin Endocrinol Diabetes. 2002 Apr;110(2):60-6.PMID: 11928067 [PubMed - indexed for MEDLINE]Related articles

    14.

    Peroxisome proliferator-activated receptor gamma polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes.

    Pollex RL, Mamakeesick M, Zinman B, Harris SB, Hegele RA, Hanley AJ.

    J Diabetes Complications. 2007 May-Jun;21(3):166-71.PMID: 17493550 [PubMed - indexed for MEDLINE]Related articles

    15.

    Association of the Pro12Ala polymorphism in the PPAR-gamma2 gene with 3-year incidence of type 2 diabetes and body weight change in the Finnish Diabetes Prevention Study.

    Lindi VI, Uusitupa MI, Lindström J, Louheranta A, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Tuomilehto J; Finnish Diabetes Prevention Study.

    Diabetes. 2002 Aug;51(8):2581-6.PMID: 12145174 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    The peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism.

    Stumvoll M, Häring H.

    Diabetes. 2002 Aug;51(8):2341-7. Review.PMID: 12145143 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    The Pro12Ala polymorphism of the PPAR gamma 2 gene regulates weight from birth to adulthood.

    Pihlajamäki J, Vanhala M, Vanhala P, Laakso M.

    Obes Res. 2004 Feb;12(2):187-90.PMID: 14981210 [PubMed - indexed for MEDLINE]Related articles

    18.

    [Association of the Pro12Ala and C1431T polymorphism of the PPAR gamma2 gene and their haplotypes with obesity and type 2 diabetes]

    Dong CP, He L, Li JN, Ye F, He M, Wang Y.

    Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2008 Aug;25(4):447-51. Chinese. PMID: 18683148 [PubMed - indexed for MEDLINE]Related articles

    19.

    Association between the Pro12Ala variant of the peroxisome proliferator-activated receptor-gamma2 gene and increased 24-h diastolic blood pressure in obese patients with type II diabetes.

    Stefański A, Majkowska L, Ciechanowicz A, Frankow M, Safranow K, Parczewski M, Moleda P, Pilarska K.

    J Hum Hypertens. 2006 Sep;20(9):684-92. Epub 2006 Apr 20.PMID: 16625233 [PubMed - indexed for MEDLINE]Related articles

    20.

    The peroxisome proliferator-activated receptor-gamma2 gene polymorphism (Pro12Ala) beneficially influences insulin resistance and its tracking from childhood to adulthood: the Bogalusa Heart Study.

    Li S, Chen W, Srinivasan SR, Boerwinkle E, Berenson GS; Bogalusa Heart Study.

    Diabetes. 2003 May;52(5):1265-9.PMID: 12716762 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity